Results 101 to 110 of about 53,102 (149)

Establishing a reference range for thromboelastography maximum amplitude in patients administrating with antiplatelet drugs. [PDF]

J Clin Lab Anal, 2020
Shen W, Zhou JY, Gu Y, Shen WY, Li M.
europepmc   +1 more source

Antiplatelet drugs: a review of pharmacology and the perioperative management of patients in oral and maxillofacial surgery. [PDF]

Ann R Coll Surg Engl, 2020
Mahmood H, Siddique I, McKechnie A.
europepmc   +1 more source

Major bleeding risk and mortality associated with antiplatelet drugs in real-world clinical practice. A prospective cohort study. [PDF]

PLoS One, 2020
Bouget J, Balusson F, Viglino D, Roy PM, Lacut K, Pavageau L, Oger E.   +6 more
europepmc   +1 more source

Safety and efficacy of dual antiplatelet drugs for stent-assisted embolization on risk of stroke and prognosis in patients with ruptured intracranial aneurysms: One center results of CIAP-5 clinical trial. [PDF]

Interv Neuroradiol
Wang S, Zhang T, Du L, Hu P, Ye M, Sun L, Hong T, Li G, Zhang P, Zhang H, He C.   +10 more
europepmc   +1 more source

Influence of Genetic and Epigenetic Factors of P2Y₁₂ Receptor on the Safety and Efficacy of Antiplatelet Drugs. [PDF]

Cardiovasc Drugs Ther
Danielak D, Pawlak K, Główka F, Karaźniewicz-Łada M.   +3 more
europepmc   +1 more source

Clinical effects of antiplatelet drugs and statins on D-dimer levels. [PDF]

Eur J Clin Invest, 2018
Schol-Gelok S, van der Hulle T, Biedermann JS, van Gelder T, Klok FA, van der Pol LM, Versmissen J, Huisman MV, Kruip MJHA.   +8 more
europepmc   +1 more source

Combining anticoagulation and antiplatelet drugs in coronary artery disease. [PDF]

Aust Prescr, 2018
Janardan J, Gibbs H.
europepmc   +1 more source

Antiplatelet Drugs and Endothelial Function

Journal of Atherosclerosis and Thrombosis, 2016
openaire   +3 more sources

Some of the next articles are maybe not open access.

Related searches:

Pharmacogenomics of oral antiplatelet drugs

Pharmacogenomics, 2014
Pharmacogenomics has been implicated in the response variability of antiplatelet drugs in coronary artery disease (CAD), particularly for aspirin and clopidogrel. A large number of studies and several meta-analyses have been published on this topic, but until recently, there have been no clear conclusions and no definite guidelines on the clinical use ...
Alfi Yasmina, Olaf H Klungel, Anthonius de Boer   +2 more
exaly   +4 more sources